Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.

Authors :: Bezin J
Mathieu C
Faillie JL
Pariente A
Source :: Diabetes care [Diabetes Care] 2023 May 01; Vol. 46 (5), pp. e121-e122.
Publication Year :: 2023

Subjects :: Humans
Glucagon-Like Peptide-1 Receptor agonists
Hypoglycemic Agents
Thyroid Neoplasms epidemiology
Diabetes Mellitus drug therapy
Diabetes Mellitus epidemiology

Full Text Access

Tools